Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2010
07/13/2010US7754223 Piscirickettsia salmonis antigens and use thereof
07/13/2010US7754222 Safe mutant viral vaccines
07/13/2010US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen
07/13/2010US7754218 Vaccines comprising aluminum adjuvants and histidine
07/13/2010US7754214 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
07/13/2010US7754212 Contraceptives based on SP22 and SP22 antibodies
07/13/2010US7754207 administering IL-16 antagonist; pneumonitis, fibrosis and sarcoidosis
07/13/2010US7754206 reducing the size of a solid tumor expressing CD44 using Notch4 antagonist
07/13/2010US7754202 used to confer a direct proliferative advantage on a genetically modified subpopulation of primary mammalian cells in response to a drug; for rendering a subpopulation of mammalian cells susceptible to drug-induced growth, proliferation and/or differentiation; treating or preventing hemopoietic diseases
07/13/2010US7754201 Method of vaccination through serotype rotation
07/13/2010CA2536807C Expression vector
07/13/2010CA2474734C Thermostable taq polymerase fragment
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2420992C Soluble zalpha11 cytokine receptors
07/13/2010CA2420350C Membrane penetrating peptides and uses thereof
07/13/2010CA2381439C Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c
07/13/2010CA2347713C Contulakin-g, analogs thereof and uses therefor
07/13/2010CA2345932C Peptide-based carrier devices for stellate cells
07/13/2010CA2324289C Combined vaccine compositions
07/13/2010CA2316280C Novel g protein-coupled receptor
07/13/2010CA2307954C Enzyme-medicated modification of fibrin for tissue engineering
07/13/2010CA2271449C Diagnosis of feline immunodeficiency virus infection using env/gag polypeptide markers
07/13/2010CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
07/13/2010CA2245242C Purified sr-p70 protein
07/13/2010CA2213082C Genes coding for proteins having acyl transferase activity
07/13/2010CA2183564C Methods for altering fertility
07/13/2010CA2176742C Composition for the in vivo production of therapeutic products
07/08/2010WO2010078325A2 Natriuretic polypeptides for reducing or preventing restenosis
07/08/2010WO2010078045A2 Method of making small liposomes
07/08/2010WO2010077890A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt9 polypeptides
07/08/2010WO2010077877A1 Treatment of early-stage osteoarthritis
07/08/2010WO2010077831A1 Targeted cytokine for treatment of diseases
07/08/2010WO2010077643A1 Masking ligands for reversible inhibition of multivalent compounds
07/08/2010WO2010077323A2 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
07/08/2010WO2010077005A2 Mycobacteria-derived polypeptide and polynucleotide, and method of screening anti-mycobacterial agent
07/08/2010WO2010076809A2 Glp-1 analogs and uses thereof
07/08/2010WO2010076768A1 Isolated peptides of rabbit factor vii
07/08/2010WO2010076766A1 Genes associated with plant tiller number and uses thereof
07/08/2010WO2010076642A1 Peptides and compositions for prevention of cell adhesion and methods of using same
07/08/2010WO2010076618A1 Combination gas vaccines and therapeutics
07/08/2010WO2010076583A1 A variant of mite allergen and uses thereof
07/08/2010WO2010076433A1 Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis
07/08/2010WO2010076361A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
07/08/2010WO2010076339A1 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
07/08/2010WO2010075986A1 Nitroprotein biomarkers for copd
07/08/2010WO2010075983A1 Process for the production of bivalirudin
07/08/2010WO2010075960A2 Method for producing riboflavin
07/08/2010WO2010075604A1 Synthetic peptides, methods and kits for diagnosing autoimmune diseases
07/08/2010WO2010052276A3 A screening assay for insecticides
07/08/2010WO2010033868A3 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
07/08/2010WO2009151337A3 Novel retinoid inducible factor and uses thereof
07/08/2010WO2009102509A8 Vaccines and diagnostics for ehrlichia chaffeensis
07/08/2010WO2009069123A8 Compositions comprising fibrous polypeptides and polysaccharides
07/08/2010WO2009024631A9 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia
07/08/2010US20100175152 Manipulation of plants by transformation with sequences promoting cell division
07/08/2010US20100175151 Rubisco activase with increased thermostability and methods of use thereof
07/08/2010US20100175150 Dof (dna binding with one finger) sequences and methods of use
07/08/2010US20100175146 Yield enhancement in plants by modulation of maize mads box transcription factor zmm28
07/08/2010US20100174061 Plants which synthesize a modified starch, process for the production thereof and modified starch
07/08/2010US20100174054 Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof
07/08/2010US20100174049 Reversed mammalian protein-protein interaction trap
07/08/2010US20100173849 Neo-tryptophan
07/08/2010US20100173844 Stable Formulations of Peptides
07/08/2010US20100173842 Vaccine for staphylococcal infections
07/08/2010US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen
07/08/2010US20100173839 Stabilized insulin-like growth factor polypeptides
07/08/2010US20100173828 Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
07/08/2010US20100173788 Biomarkers for breast cancer
07/08/2010US20100173430 Cysteine-tagged staphylococcal protein g variant
07/08/2010US20100173427 Levetiracetam immunoassays
07/08/2010US20100173412 Eukaryotic Layered Vector Initiation Systems
07/08/2010US20100173408 Receptor-based interaction trap
07/08/2010US20100173404 Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
07/08/2010US20100173389 Process for bacterial production of polypeptides
07/08/2010US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/08/2010US20100173386 Prokaryotic expansin protein activating cellulose expansion and cellulose - degrading composition comprising the same
07/08/2010US20100173384 Methods for protein labeling based on acyl carrier protein
07/08/2010US20100173383 Nuclear Factor Of Activated T Cells Receptor
07/08/2010US20100173352 Method for preparing cells for engraftment
07/08/2010US20100173349 Cellular Libraries of Peptide Sequences (CLiPS) and Methods of Using the Same
07/08/2010US20100173331 Novel notch-origin polypeptides and biomarkers and reagents using the same
07/08/2010US20100173329 Exposed proliferation-related peptides, ligands and methods employing the same
07/08/2010US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration
07/08/2010US20100173314 Diagnostic methods using tenascin-w compositions
07/08/2010US20100173302 Positive control proteins for glucose transporter proteins and processes for the generation of such positive control proteins
07/08/2010US20100173299 Mutant nucleic acid related to chronic myeloproliferative disorder and method of evaluating chronic myeloproliferative disorder
07/08/2010US20100173298 Hcv gene
07/08/2010US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/08/2010US20100173292 NOVEL GPIIIa GENE
07/08/2010US20100173282 Mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
07/08/2010US20100173064 Novel canola protein isolate
07/08/2010US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof
07/08/2010US20100172968 Chimeric cannulae proteins and methods for making and using them
07/08/2010US20100172949 Consensus peptide
07/08/2010US20100172938 Modified bacterial surface layer proteins
07/08/2010US20100172936 Chimeric papillomavirus-like particles
07/08/2010US20100172932 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
07/08/2010US20100172931 Pharmaceutical Composition Containing the NMB1796 Protein
07/08/2010US20100172930 Transfection complexes
07/08/2010US20100172929 Malaria Vaccines
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 2916